British Broadcasting Corporation

Page last updated at 09:01 GMT, Wednesday, 2 April 2008 10:01 UK

Sickness drug extension approved

A syringe
The company believes sales of the drug will rise sharply

A Borders pharmaceutical firm has been cleared to market an anti-sickness drug in the UK and Germany.

Galashiels-based ProStrakan has estimated the total value of the German market could be more than £10m.

It already sells the drug - designed to treat post-operative nausea - in eight other European countries.

Sales of xomolix totalled £4.2m in 2007 and the company believes there is a "substantial level" of demand for the product in the new nations.

A total of eight countries are involved in the new marketing clearance.




SEE ALSO
Drugs firm seeks US breakthrough
22 Oct 07 |  South of Scotland
Borders firm nets £74m drug deal
28 Sep 06 |  South of Scotland
East European deal for drugs firm
27 Jul 06 |  South of Scotland
Scots firm announces huge US deal
14 Jul 06 |  South of Scotland

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites


FEATURES, VIEWS, ANALYSIS
Witnesses and relatives recount Mumbai horrors
Sahara reality TV show to highlight climate change
Muslim pilgrims undertake the Hajj amid heavy rainfall

PRODUCTS & SERVICES

Explore the BBC

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.
Americas Africa Europe Middle East South Asia Asia Pacific